DE3485972D1 - ANTIG ACTIVE AMINO ACID SEQUENCES. - Google Patents

ANTIG ACTIVE AMINO ACID SEQUENCES.

Info

Publication number
DE3485972D1
DE3485972D1 DE8484900954T DE3485972T DE3485972D1 DE 3485972 D1 DE3485972 D1 DE 3485972D1 DE 8484900954 T DE8484900954 T DE 8484900954T DE 3485972 T DE3485972 T DE 3485972T DE 3485972 D1 DE3485972 D1 DE 3485972D1
Authority
DE
Germany
Prior art keywords
leu
amino acid
gln
val
asp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484900954T
Other languages
German (de)
Other versions
DE3485972T2 (en
Inventor
Mario Geysen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
Commonwealth Serum Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Serum Laboratories filed Critical Commonwealth Serum Laboratories
Priority claimed from PCT/AU1984/000038 external-priority patent/WO1984003506A1/en
Application granted granted Critical
Publication of DE3485972D1 publication Critical patent/DE3485972D1/en
Publication of DE3485972T2 publication Critical patent/DE3485972T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/222—Foot and mouth disease related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Synthetic peptide (I) displaying the antigenicity of the VP1 protein of foot-and-mouth disease virus is new. At least part of the (I) is a 5-, 6- or 7-long antigenically active amino acid sequence of the VP1 protein, or an antigenically active modified sequence. Synthetic peptides having the antigenicity of Type O(1) virus are pref. of formulae (II)-(V) Gly-Asp-Leu-Gln-Val-Leu-Ala (II) Gly-Asp-Leu-Gln-Val-Leu (III) Asp-Leu-Gln-Val-Leu-Ala (IV) Asp-Leu-Gln-Val-Leu (V)
DE8484900954T 1983-03-08 1984-03-08 ANTIG ACTIVE AMINO ACID SEQUENCES. Expired - Fee Related DE3485972T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU834783 1983-03-08
PCT/AU1984/000038 WO1984003506A1 (en) 1983-03-08 1984-03-08 Antigenically active amino acid sequences

Publications (2)

Publication Number Publication Date
DE3485972D1 true DE3485972D1 (en) 1992-12-10
DE3485972T2 DE3485972T2 (en) 1993-04-08

Family

ID=25612908

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484900954T Expired - Fee Related DE3485972T2 (en) 1983-03-08 1984-03-08 ANTIG ACTIVE AMINO ACID SEQUENCES.

Country Status (1)

Country Link
DE (1) DE3485972T2 (en)

Also Published As

Publication number Publication date
DE3485972T2 (en) 1993-04-08

Similar Documents

Publication Publication Date Title
DK532184A (en) ANTIGEN AMINO ACID SEQUENCES
EP0330506A3 (en) Vla proteins
PT97159A (en) A process for the preparation of a hepatitis B surface antigen or a fragrance thereof and a method for the preparation of a vaccine
FI910720A0 (en) SYNTHETIC PEPTIDER SPECIFIC FOER DETEKTERING AV HCV ANTIKROPPAR, DIAGNOS AV HCV INFEKTION OCH PREVENTION AV INFEKTIONEN SOM VACCIN.
ES2101388T3 (en) SYNTHETIC ANTIGENS FOR THE DETECTION OF ANTIBODIES FOR THE HEPATITIS C VIRUS.
FI932561A0 (en) Protein with intact epithelium and pharyngeal protein
ATE188612T1 (en) CONJUGATES OF WEAKLY IMMUNOGENIC ANTIGENS AND SYNTHETIC PEPTIDE CARRIERS AND VACCINES CONTAINING SAME
KR850006548A (en) Peptide Hepatitis B Immunogen, waxin, diagnostic method and synthetic lipid vesicle carrier with pre-S gene code
DK152082A (en) APPLICATION OF RADIO-MARKED PEPTID DERIVED BY CIRCULATED FIBRIN TO LOCATE BLOOD PROBLEMS IN VIVO
ATE171710T1 (en) HCV PEPTIDE ANTIGENS AND METHODS FOR DETERMINING HCV
MX167236B (en) SYNTHETIC PEPTIDES OF THYMOSINE -1 AND METHOD FOR OBTAINING THEM
ATE116660T1 (en) ARTIFICIAL PEPTIDE COMPOSITIONS WITH IMMUNOREACTIVE ANTIBODIES OF HTLV-1.
DE3485972D1 (en) ANTIG ACTIVE AMINO ACID SEQUENCES.
ES2060927T3 (en) ANTIBODIES AGAINST FIBRIN; PROPER IMMUNOGEN PEPTIDES FOR PREPARING ANTIBODIES, METHOD FOR DETERMINING FIBRIN AND ANTIBODY BASED PHARMACEUTICAL PREPARATION.
PT99791A (en) PROCESS FOR THE PREPARATION OF SELECTED PEPTIDES FROM THE SPECIFIC GROUP ANTIGEN (GAS) OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ATE98962T1 (en) HUMAN RHINOVIRUS PEPTIDES.
ATE201697T1 (en) ANTIGEN PEPTIDES WITH GLYCINE SUBSTITUTION
DK230090D0 (en) PEPTIDES
FI870501A0 (en) Method for producing an antigenic peptide or antigenic protein derived from the melanoma-associated antigen p97 and useful recombinant viruses, recombinant vectors and host cells.
ES1027961U (en) Advertising support for pushchairs. (Machine-translation by Google Translate, not legally binding)
DK53290A (en) SYNTHETIC GAER LEADER PEPTIDES
SE8605513L (en) NEW PEPTID AND IMMUNOLOGICALLY ACTIVE ASSOCIATIONS
TH7280A (en) Peptides that are non-A, non-B hepatitis antigens.
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DIE PATENTINHABER LAUTEN RICHTIG: CHIRON MIMOTOPES PTY. LTD., CLAYTON, VICTORIA, AU STICHTING CENTRAAL DIERGENEESKUNDIG INSTITUUT, LELYSTAD, NL

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee